AVEO Pharma
AcquiredCambridge, United States · Founded 2003 · $53.0M raised
- Headquarters
- Cambridge, Massachusetts
- Employees
- 51–200
- Founded
- 2003
- Business Model
- B2B
- Total Funding
- $53.0M
- Last Round
- $53.0M Series DApr 2007
- Rounds
- 4
- Acquisition Date
- Nov 2022
About
Oncology-focused biopharmaceutical company developing targeted medicines for cancer patients; subsidiary of LG Chem since 2023.
Summary
AVEO Pharma is a Biotech company based in Cambridge, United States, founded in 2003. It has raised $53.0M in total across 4 rounds, most recently a $53.0M Series D round in Apr 2007. Investors include Bessemer VP, Merlin BioMed Group and Biogen.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Nov 2022
Sign up to see all 7 rounds
Series A through Acquisition — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Specialty pharmaceutical company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/aveo-pharma"><img src="https://indexed.vc/api/badge/company/aveo-pharma" alt="AVEO Pharma on Indexed.vc" width="260" height="76" /></a>